AmerisourceBergen Corp (ABC)

81.22
0.17 0.21
NYSE : Services
Prev Close 81.05
Open 80.23
Day Low/High 80.14 / 80.98
52 Wk Low/High 68.38 / 97.85
Volume 92.97K
Avg Volume 1.52M
Exchange NYSE
Shares Outstanding 219.11M
Market Cap 17.61B
EPS 6.70
P/E Ratio 20.93
Div & Yield 1.46 (1.80%)

Latest News

Teva's Massive Debt Load Just Became an Even Bigger Issue

Teva's Massive Debt Load Just Became an Even Bigger Issue

It is just not going to get better anytime soon.

Teva Shares Are Getting Obliterated Again After Vicious Investment Bank Downgrades

Teva Shares Are Getting Obliterated Again After Vicious Investment Bank Downgrades

Teva's stock is crumbling as another analyst slams it with a downgrade.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEL, CNMD, DATA, IAC, KBR, KHC, KOP, NPO, PBR.A, REG, SHAK, SQ, STOR, WMS, XPO Downgrades: ABC, AXTA, BIO, BIO.B, CNSL, DISH, GNE, HL, MCS, TGP, TNK, WEYS, WRLD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers

Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers

Teva said weak U.S. markets and the ongoing political turmoil in Venezuela weighed on the company's second quarter performance.

AmerisourceBergen Reports Third Quarter Fiscal Year 2017 Results

AmerisourceBergen Reports Third Quarter Fiscal Year 2017 Results

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2017 third quarter ended June 30, 2017, revenue increased 4.

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

The deal is worth $1.4 billion and PharMerica's board has already given it the green light.

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

McCaskill requested that four more drug companies and three drug distributors turn over documents.

Teamsters Mark Victory Against Executive Pay at Drug Titan McKesson

Teamsters Mark Victory Against Executive Pay at Drug Titan McKesson

McKesson faced some opposition at its shareholder meeting from an unconventional activist investor—a labor union.

Teamsters to Protest McKesson's Shareholder Meeting Wednesday

Teamsters to Protest McKesson's Shareholder Meeting Wednesday

ISS and Glass, Lewis echo the union's call for management to address the drug distributor's role in the opioid crisis.

AmerisourceBergen Announces Date And Time For Third Quarter Fiscal 2017 Earnings Release

AmerisourceBergen Announces Date And Time For Third Quarter Fiscal 2017 Earnings Release

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2017 on Thursday, August 3, 2017 prior to the opening of trading on the New York Stock Exchange.

AmerisourceBergen Structures Operating Model And Executive Leadership Team To Offer A More Cohesive And Unified Customer Experience, Enhance Growth And Drive Long-Term Value

AmerisourceBergen (NYSE: ABC) today announced a new organizational structure designed to further align the organization to its customer needs in a more seamless and unified way, while supporting corporate strategy and...

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..

Eyes Are on McKesson's Guidance

Eyes Are on McKesson's Guidance

The drug distributor is scheduled to report quarterly results after the market close on Thursday.

Analysts' Actions -- AMD, Clovis, ConocoPhillips, Disney, Transocean and More

Analysts' Actions -- AMD, Clovis, ConocoPhillips, Disney, Transocean and More

Here are Wednesday's top research calls, including new coverage of Advanced Micro Devices and Transocean, upgrades for Clovis Oncology and ConocoPhillips, and a downgrade for Disney.

AmerisourceBergen Declares Quarterly Dividend

The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) today declared a quarterly dividend of $0.

AmerisourceBergen Reports Second Quarter Fiscal Year 2017 Results

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2017 second quarter ended March 31, 2017, revenue increased 4.

Correction Is Over for AmerisourceBergen

It's time to go long.

AmerisourceBergen Announces New Five-Year Pharmaceutical Supply Agreement With Express Scripts

AmerisourceBergen Corporation (NYSE:ABC) announced today that it has signed a new five-year agreement to supply pharmaceuticals to Express Scripts Holding Company (Nasdaq: ESRX).

Bullish and Bearish Reversals for This Week

Bullish and Bearish Reversals for This Week

Financial names populate the bullish side.

AmerisourceBergen Announces Date And Time For Second Quarter Fiscal 2017 Earnings Release

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter Fiscal 2017 on Thursday, May 4, 2017 prior to the opening of trading on the New York Stock Exchange.

Short Interest In AmerisourceBergen Expands By 12.8%

The most recent short interest data has been released for the 02/28/2017 settlement date, which shows a 1,889,255 share increase in total short interest for AmerisourceBergen Corp. , to 16,609,081, an increase of 12.83% since 01/31/2017.

Obamacare Repeal Heads to House Floor After 18 Hours of Debate

Obamacare Repeal Heads to House Floor After 18 Hours of Debate

The Ways and Means panel had it easy compared to the Energy and Commerce Committee, which was still debating Democratic amendments Thursday morning-roughly 24 hours after beginning debate.

2 Health-Care Stocks Ready to Break Out

2 Health-Care Stocks Ready to Break Out

Akorn and AmerisourceBergen are both flashing big moves, but in which direction is unclear.

Here's Why AmerisourceBergen Is Up 16% This Year

Here's Why AmerisourceBergen Is Up 16% This Year

The pharmaceutical distributor is finally turning around.

AmerisourceBergen Declares Quarterly Dividend

The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) today declared a quarterly dividend of $0.

Buy Retail, Pharma, Health-Care on Dips

Buy Retail, Pharma, Health-Care on Dips

Demographics will continue to favor health-care and pharmaceutical companies.

AmerisourceBergen Reports First Quarter Fiscal Year 2017 Results

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2017 first quarter ended December 31, 2016, revenue increased 4 percent to $38.

Winning Stocks Are Right in Front of Your Eyes: Cramer's 'Mad Money' Recap (Thursday 1/26/17)

Winning Stocks Are Right in Front of Your Eyes: Cramer's 'Mad Money' Recap (Thursday 1/26/17)

Jim Cramer says it's not hard to find great American companies that have soared from Dow 10,000 to Dow 20,000.

TheStreet Quant Rating: C (Hold)